(Total Views: 206)
Posted On: 06/09/2022 1:35:51 PM
Post# of 24

$CLBS News Article - Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials Group https://marketwirenews.com/news-releases/cala...50229.html


My Twitter: WhyteStocks